Jonathan Fellus
Neurology · Randolph, NJNPI 1053309195
Payments from drug & device makers
Across 109 payments — averaging $31.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$550
- Jazz Pharmaceuticals Inc.$519
- Janssen Scientific Affairs, LLC$400
- Johnson & Johnson$354
- Axsome Therapeutics, Inc.$345
- Avadel CNS Pharmaceuticals, LLC$313
- plus $927 from 16 others
What the payments were for
- Consulting fees$60018%
- Food & beverage$2,66578%
- Education$1444%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 22 | $550 |
| Jazz Pharmaceuticals Inc. | 14 | $519 |
| Janssen Scientific Affairs, LLC | 2 | $400 |
| Johnson & Johnson | 3 | $354 |
| Axsome Therapeutics, Inc. | 27 | $345 |
| Avadel CNS Pharmaceuticals, LLC | 7 | $313 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $229 |
| Eisai Inc. | 3 | $144 |
| Neurelis, Inc. | 1 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Acorda Therapeutics, Inc | 5 | $76 |
| Lilly USA, LLC | 3 | $59 |
| Avanir Pharmaceuticals, Inc. | 4 | $57 |
| Pfizer | 2 | $34 |
| Biogen | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Amgen | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Argenx US, Inc. | 1 | $15 |
| Merz Pharmaceuticals, LLC | 1 | $15 |
| Bausch Health US, LLC | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,409 in reported general payments places this provider in the 55th percentile of 521 neurology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuedextaDextromethorphan Hbr/Quinidine | 46 | $70,131 |
| RexultiBrexpiprazole | 19 | $35,474 |
| AuvelityDextromethorphan Hbr/Bupropion | 20 | $23,848 |
| TopamaxTopiramate | 20 | $13,811 |
| TrintellixVortioxetine Hydrobromide | 23 | $10,501 |
| OxycontinOxycodone Hcl | 13 | $7,523 |
| Memantine Hcl ErMemantine Hcl | 79 | $5,792 |
| Lisdexamfetamine Dimesylate | 12 | $3,346 |
| Rivastigmine | 33 | $2,487 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 23 | $2,431 |
| Galantamine ErGalantamine Hbr | 14 | $1,793 |
| Gabapentin | 69 | $1,701 |
| Desmopressin Acetate | 12 | $810 |
| Divalproex Sodium | 14 | $804 |
| AmantadineAmantadine Hcl | 16 | $616 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Avanir Pharmaceuticals, Inc.Nuedexta | $57 | $70,13146 claims |
| Axsome Therapeutics, Inc.Auvelity | $345 | $23,84820 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $87 | $10,50123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 521 neurology providers in New Jersey.
Other neurology in Randolph
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- David DuncanNeptune$1.5M
- Lana Zhovtis RyersonNeptune$1.3M
- Amos KatzEatontown$1.2M
- Fiona GuptaOradell$1.1M
- Andrew SylvesterBridgewater$1.1M
- Machteld HillenNewark$999K
- Matthew TremblayLivingston$812K
- Noah GilsonWest Long Branch$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.